Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
D000818:Animals; D030801:Animals, Genetically Modified; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D015796:HLA-B27 Antigen / Q000235:genetics*; D017228:Hepatocyte Growth Factor / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D007262:Infusions, Intravenous; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D051381:Rats; D011916:Rats, Inbred F344; D012038:Regeneration / Q000187:drug effects
D015796:HLA-B27 Antigen; D017228:Hepatocyte Growth Factor